Pharmacogenetics in solid organ transplantation: current status and future directions
H de Jonge, DRJ Kuypers - Transplantation Reviews, 2008 - Elsevier
Tailoring of immunosuppressive drug therapy to the specific requirements of the individual
patient to optimize efficacy and minimize toxicity remains one of the biggest challenges in …
patient to optimize efficacy and minimize toxicity remains one of the biggest challenges in …
Pharmacogenetics in solid organ transplantation: current status and future directions.
H de Jonge, DR Kuypers - Transplantation Reviews (Orlando, Fla.), 2008 - europepmc.org
Tailoring of immunosuppressive drug therapy to the specific requirements of the individual
patient to optimize efficacy and minimize toxicity remains one of the biggest challenges in …
patient to optimize efficacy and minimize toxicity remains one of the biggest challenges in …
Pharmacogenetics in solid organ transplantation: current status and future directions
H de Jonge, DRJ Kuypers - Transplantation Reviews, 2008 - infona.pl
Tailoring of immunosuppressive drug therapy to the specific requirements of the individual
patient to optimize efficacy and minimize toxicity remains one of the biggest challenges in …
patient to optimize efficacy and minimize toxicity remains one of the biggest challenges in …
Pharmacogenetics in solid organ transplantation: current status and future directions
H de Jonge, DRJ Kuypers - … reviews (Orlando, Fla.), 2008 - pubmed.ncbi.nlm.nih.gov
Tailoring of immunosuppressive drug therapy to the specific requirements of the individual
patient to optimize efficacy and minimize toxicity remains one of the biggest challenges in …
patient to optimize efficacy and minimize toxicity remains one of the biggest challenges in …